Arena Pharmaceuticals (NASDAQ:ARNA) have announced that CEO Jack Lief will be retiring from his position at the company and in addition will vacate his board seat. The news came after the market closed today. Arena stock traded up throughout the …
Seeking Alpha · BySpencer Osborne · 1 day ago
or a 17.1% annualized rate of return (at Stock Options Channel we call this the YieldBoost). START SLIDESHOW: Top YieldBoost Puts of the S&P 500 » Selling a put does not give an investor access to ARNA's …
The Street · 2 hours ago
Arena Pharmaceuticals
Arena Pharmaceuticals Inc (NASDAQ:ARNA) remained among the day gainers and traded with volume of 3.35 million shares in the last session, as compared to average volume of 2.87 million shares. The stock · 1 day ago
More from Bing News
Arena Pharmaceuticals (NASDAQ:ARNA) has earned a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated … · 9/29/2015
Arena Pharmaceuticals (NASDAQ:ARNA) shares traded down 4.7% during trading on Tuesday , Analyst Ratings.Net reports. The company traded as low as $1.92 and last traded at $2.02, with a volume of 2,421,107 shares changing hands. The stock had … · 9/30/2015
F5 Networks (NASDAQ: FFIV) 5.5% LOWER; Citi initiated coverage with a Sell rating and a price target of $105.0 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) 4.7% HIGHER ... up to $125 million of its common …
StreetInsider · 1 day ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has been on quite a roller coaster ride in 2015. A few weeks ago, ARNA shares roared 76% higher in a single day after positive early-stage trials for an autoimmune disease treatment gave investors a …
Investor Place · 1/22/2015
San Diego-based Arena Pharmaceuticals (NASDAQ: ARNA) said that Jack Lief ... and an acceleration of his stock options and restricted, performance-based stock that would have vested over the next 18 months.
Xconomy · ByBruce V. Bigelow · 10/5/2015
Jack Lief
Arena Pharmaceuticals' ($ARNA) board of directors is getting its way ... 18 months of continued health insurance coverage, and acceleration of the stock options and RSUs that would have vested over the next year and a half. Harry Hixson, one of the ...
FiercePharma · 1 day ago
The stock is trading at a price to book ratio of 4.78 while the historical PB ratio is close to 16.15. The complete research on ARNA is available for free at: Allscripts Healthcare Solutions Inc. Allscripts ...
Market Watch · 9/29/2015